| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Physiologically Based Pharmacokinetic Model of Vismodegib: Deconvoluting the Impact of Saturable Plasma Protein Binding, pH-Dependent Solubility and Nonsink Permeation
|
Dolton, Michael J.
|
|
|
22 |
5 |
|
artikel
|
| 2 |
Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score Data
|
Hu, Chuanpu
|
|
|
22 |
5 |
|
artikel
|
| 3 |
Application of Trial Simulation in the Design of a Prospective Study for Concentration-QTc Analysis in Support of a Thorough QT Study Waiver
|
Zhu, Peijuan
|
|
|
22 |
5 |
|
artikel
|
| 4 |
A Regulatory Perspective on Manufacturing Processes Pertaining to Lyophilized Injectable Products
|
Rhieu, Steve Y.
|
|
|
22 |
5 |
|
artikel
|
| 5 |
Association Between Vomiting and QT Hysteresis: Data from a TQT Study with the Endothelin A Receptor Antagonist Clazosentan
|
Juif, Pierre-Eric
|
|
|
22 |
5 |
|
artikel
|
| 6 |
A Three-Treatment Two-Stage Design for Selection of a Candidate Formulation and Subsequent Demonstration of Bioequivalence
|
Fuglsang, Anders
|
|
|
22 |
5 |
|
artikel
|
| 7 |
Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability
|
Bodin, Jonathan
|
|
|
22 |
5 |
|
artikel
|
| 8 |
Capturing the Magic Bullet: Pharmacokinetic Principles and Modeling of Antibody-Drug Conjugates
|
Zuo, Peiying
|
|
|
22 |
5 |
|
artikel
|
| 9 |
Challenge-Enabled Machine Learning to Drug-Response Prediction
|
Wang, Ziyan
|
|
|
22 |
5 |
|
artikel
|
| 10 |
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
|
Liu, Dan
|
|
|
22 |
5 |
|
artikel
|
| 11 |
Correction to: Equivalence Testing of Complex Particle Size Distribution Profiles Based on Earth Mover’s Distance
|
Hu, Meng
|
|
|
22 |
5 |
|
artikel
|
| 12 |
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit
|
Sun, Duxin
|
|
|
22 |
5 |
|
artikel
|
| 13 |
Design and Evaluation of a Multiplexed Assay to Assess Human Immunogenicity Against Humira®
|
Alleyn, Matthew
|
|
|
22 |
5 |
|
artikel
|
| 14 |
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo
|
Intagliata, Sebastiano
|
|
|
22 |
5 |
|
artikel
|
| 15 |
Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data
|
Partridge, Michael A.
|
|
|
22 |
5 |
|
artikel
|
| 16 |
Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity Risk
|
Wickramarachchi, Dilki
|
|
|
22 |
5 |
|
artikel
|
| 17 |
HIV-1 Sanctuary Sites—the Role of Membrane-Associated Drug Transporters and Drug Metabolic Enzymes
|
Whyte-Allman, Sana-Kay
|
|
|
22 |
5 |
|
artikel
|
| 18 |
Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
|
Lyauk, Yassine Kamal
|
|
|
22 |
5 |
|
artikel
|
| 19 |
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
|
Selen, Arzu
|
|
|
22 |
5 |
|
artikel
|
| 20 |
Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds
|
Melillo, Nicola
|
|
|
22 |
5 |
|
artikel
|
| 21 |
Investigating the Theoretical Basis for In Vitro–In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways
|
Benet, Leslie Z.
|
|
|
22 |
5 |
|
artikel
|
| 22 |
Item Response Theory Modeling of the International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
|
Lyauk, Yassine Kamal
|
|
|
22 |
5 |
|
artikel
|
| 23 |
Pitfalls in Predicting Hepatobiliary Drug Transport Using Human Sandwich-Cultured Hepatocytes
|
Kumar, Vineet
|
|
|
22 |
5 |
|
artikel
|
| 24 |
PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy
|
Xie, Feifan
|
|
|
22 |
5 |
|
artikel
|
| 25 |
The Effects of Dose Volume and Excipient Dose on Luminal Concentration and Oral Drug Absorption
|
Aungst, Bruce J.
|
|
|
22 |
5 |
|
artikel
|
| 26 |
The Necessity of Using Changes in Absorption Time to Implicate Intestinal Transporter Involvement in Oral Drug-Drug Interactions
|
Sodhi, Jasleen K.
|
|
|
22 |
5 |
|
artikel
|
| 27 |
Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric Populations
|
Miao, Lei
|
|
|
22 |
5 |
|
artikel
|
| 28 |
Using Physiologically Based Pharmacokinetic Modeling to Assess the Risks of Failing Bioequivalence Criteria: a Tale of Two Ibuprofen Products
|
Loisios-Konstantinidis, Ioannis
|
|
|
22 |
5 |
|
artikel
|
Tijdschrift beschrijving